University of Tokyo Hospital

Bunkyō City 113-8655

1 studies enrolling now · 3 studies all time

What they study most

Adult-type Diffuse Gliomas, Glioblastoma, Metastatic Cholangiocarcinoma, Pulmonary Arterial Hypertension, Unresectable Cholangiocarcinoma

Studies at this site

• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early